Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Casma Therapeutics is a biotechnology company harnessing the natural cellular process of autophagy to design new medicines.
Syremis Therapeutics is developing novel medicines to make a profound impact on the treatment of mental health disorders.
Azalea Therapeutics is a biotechnology company with a primary focus on developing cancer immunotherapies.
ARTBIO is a clinical-stage radiopharmaceutical biotechnology business that is working to create a new class of alpha radioligand medicines.
Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics
Merida Biosciences is a biotech company focused on developing precision treatments, particularly for autoimmune diseases.
Trace Neuroscience is a biopharmaceutical company that aims to extend the promise of genetic medicine to patients.
Red Arrow Therapeutics is a biotech firm that provides systemic cytokine delivery, targeted intratumoral activation, and biological potency.
Marea is a biotechnology company that develops therapies and medications for the treatment of cardioendocrine illness patients.
Clasp Therapeutics offers to reach of immuno-oncology with novel precision medicines that enable the immune system.
Synnovation Therapeutics is a precision oncology company that develops therapeutics that aims to help people with cancer.
Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines.
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
MOMA Therapeutics operates as a biotechnology company.
Allena Pharmaceuticals develops and commercializes non-systemic protein therapeutics to treat metabolic and orphan diseases.
Ambys Medicines is a biotechnology company focused on discovering and developing regenerative and restorative therapies.
SAGE Therapeutics develops and delivers novel medicines for most debilitating and disabling central nervous system disorders.
Alcresta develops enzyme-based nutritional products for infants and adults with acute and chronic diseases.
Sesen Bio is focused on developing innovative protein-based therapeutics to improve human health and treat diseases.
A biopharmaceutical company developing novel medicines that modulate metabolic pathways in immune cells to treat disease.
Cibiem, a medical device company, develops minimally invasive, catheter-based therapeutics for sympathetic nervous system-mediated diseases.
Rhythm Metabolic develops a novel peptide MC4 agonist for the treatment of obesity caused by genetic deficiencies.
Foundation medicine is a molecular information company developing clinical diagnostic tests that facilitates personalized cancer therapies.
Third Rock Ventures has invested in 50 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Third Rock Ventures's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 19 different industry categories.
Among tracked funding rounds, SAGE Therapeutics received $650.0M in a Post Ipo Equity round. Third Rock Ventures's total known invested capital is $6.1B.
Third Rock Ventures's average investment size is $136.5M across its portfolio of 50 companies.
Recent Third Rock Ventures portfolio additions include Cedilla Therapeutics, Casma Therapeutics, Syremis Therapeutics, Azalea Therapeutics, ARTBIO. These companies were founded in 2020 or later.